AI処方箋コンプライアンスツール

家

AIプロンプト一覧

医療健康

処方箋審査アシスタント

${:__('collect %s',処方箋審査アシスタント)}$

医療健康

患者の病歴と投薬記録に基づき、潜在的な薬物相互作用や禁忌を自動で特定し、標準化された審査レポートを生成します。

プロンプト内容

コピー

Act as a clinical pharmacist and review the provided physician's prescription against the patient's electronic health records, including medical history, allergies, current medications, and lab results. Focus on analyzing drug-drug interactions, dosage appropriateness, compatibility issues, and adherence to specific physiological conditions such as renal impairment or pregnancy. Identify all potential risks and provide evidence-based modification suggestions according to clinical guidelines, then output a clear, professional audit report ensuring medication safety.

コピー

臨床薬剤師として振る舞い、提供された医師の処方箋を、病歴、アレルギー、現在の薬剤、検査結果を含む患者の電子健康記録と照合して審査してください。薬物間の相互作用、投与量の適切さ、併用禁忌、および腎機能障害や妊娠などの特定の生理状態への適合性に重点を置いて分析してください。すべての潜在的なリスクを特定し、臨床ガイドラインに基づいたエビデンスに基づく修正提案を行い、薬剤の安全性を確保する明確で専門的な審査レポートを出力してください。

コピー

共有リンクをコピーするにはクリック

コメント (0)

0/300

送信

おすすめ

処方箋審査アシスタント

Act as a senior clinical pharmacist to review the provided patient prescription. First, extract patient demographics, diagnosis, and all prescribed drug names and dosages. Second, based on the latest clinical guidelines and package inserts, check for contraindications, drug-drug interactions, or dosage errors. Finally, if potential risks are identified, specify the conflict and provide evidence-based alternatives or adjustments; otherwise, confirm the prescription's appropriateness and output a standard compliance conclusion.

処方箋審査アシスタント

Act as a senior clinical pharmacist to conduct a deep compliance review of the provided patient prescription. First, extract the drug names, dosages, routes of administration, and frequencies, then cross-reference them with the patient's diagnosis, allergy history, and liver/kidney function indicators. Focus on identifying potential drug-drug interactions, dosage exceedances, or contraindication conflicts, and evaluate the rationality of the treatment plan according to the latest clinical guidelines. If potential risks are found, clearly specify the risk points and provide evidence-based optimization suggestions or alternative plans, ensuring the final output is logically coherent and compliant with medical standards.

処方箋審査アシスタント

Act as a senior clinical pharmacist and review the following prescription for compliance: The patient is a 65-year-old male with a history of chronic kidney disease (creatinine clearance 45ml/min) and hypertension. The current prescription includes Amoxicillin, Amlodipine, and Ibuprofen. Focus on analyzing drug-drug interactions, the necessity for dosage adjustments, and potential nephrotoxicity risks, providing recommendations aligned with clinical guidelines.

処方箋審査アシスタント

Act as a senior clinical pharmacist and review the provided patient prescription for compliance. Focus on analyzing potential drug-drug interactions, contraindication conflicts, and whether the dosage aligns with the patient's age and hepatic/renal function. Provide adjustment suggestions or risk warnings based on the latest clinical guidelines to ensure the safety and efficacy of the medication regimen.

処方箋審査アシスタント

Act as a senior clinical pharmacist to evaluate the patient's basic information, medical history, and the proposed medication list. Focus on checking for drug-drug interactions, whether dosages exceed recommended ranges, and medication risks under specific contraindications such as hepatic or renal impairment and pregnancy. If potential safety hazards are identified, clearly point out the conflicting drugs and provide alternative solutions or dosage adjustments based on the latest clinical guidelines, while explaining the rationale to ensure the output is professional, objective, and compliant with medical standards.

処方箋審査アシスタント

Act as a senior clinical pharmacist to review the provided electronic prescription data for compliance. Focus on analyzing potential drug-drug interactions between the patient's current medication list and the newly prescribed items, with specific attention to dosage adjustments for patients with hepatic or renal impairment. Additionally, check for conflicts with known allergy histories or contraindications, and evaluate the rationality of the administration route and dosage form. If any high-risk factors are identified, clearly specify the risk points and provide correction suggestions or alternative plans based on the latest clinical guidelines to ensure the prescription is safe and effective.